Pain News and Research

Latest Pain News and Research

Adolescents with joint hypermobility more likely to develop musculoskeletal pain

A prospective study by U.K. researchers found that adolescents who are double-jointed-medically termed joint hypermobility-are at greater risk for developing musculoskeletal pain as they get older, particularly in the shoulders, knees, ankles and feet.

28 Feb 2013

Scientists identify two populations of human cells that migrate to the intestine

Researchers at Wake Forest Baptist Medical Center and colleagues have identified a special population of adult stem cells in bone marrow that have the natural ability to migrate to the intestine and produce intestinal cells, suggesting their potential to restore healthy tissue in patients with inflammatory bowel disease (IBD).

28 Feb 2013

Anesthetics during breast cancer surgery may affect development of chronic pain

In women with breast cancer, the choice of anesthetic used for mastectomy may affect the risk of developing long-term pain after surgery, according to a study in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

28 Feb 2013

Primary care practices discriminating on socioeconomic status

An audit of family physician and general practitioner offices in Canada reveals that patients with lower incomes are subject to discrimination when trying to access primary care.

27 Feb 2013

Ampio Pharmaceuticals starts Optina clinical trial

Ampio Pharmaceuticals, Inc. announced oral dosing of the first patient in a 505(b)(2) clinical trial of the investigational drug Optina in diabetic macular edema.

27 Feb 2013

Study shows people of high socioeconomic status more likely to get access to primary care

People of high socioeconomic status are more likely to be able to access primary care than those of low socioeconomic status, even within a universal health care system in which physicians are reimbursed equally for each patient, found an article published in CMAJ.

27 Feb 2013

Offices of family physicians appear to give preference to people with chronic health conditions

Some family physicians' offices discriminate against people of low socio-economic status, even when there is no economic incentive to do so under Canada's system of publicly funded universal health insurance, new research has shown.

27 Feb 2013

New journal aims to address fatigue in medical illnesses and specific environmental conditions

With peer-reviewed articles on fatigue having increased 90% over the past decade - and nearly 1,000 papers on the topic published in 2011 alone - the time is right for Routledge's new journal, Fatigue: Biomedicine, Health & Behavior.

27 Feb 2013

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) supplement to the U.S. Food and Drug Administration (FDA) for the approval of prophylaxis treatment of FEIBA NF [Anti-Inhibitor Coagulant Complex], Nanofiltered and Vapor Heated, in patients with hemophilia A or B and inhibitors.

From Baxter International Inc. 26 Feb 2013

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

26 Feb 2013

Learned helplessness role in inflammatory polyarthritis revealed

Learned helplessness is a modifiable risk factor that can significantly influence disease outcome in patients with inflammatory polyarthritis, UK clinicians believe.

26 Feb 2013

High-level results from AstraZeneca’s naloxegol Phase III trial on opioid-induced constipation

AstraZeneca today announced high-level results from KODIAC-08, an open-label, randomised, 52-week, long-term safety trial of naloxegol versus usual care (UC) in patients with non-cancer related pain and opioid-induced constipation (OIC). UC was defined as the investigator's choice of an existing laxative treatment regimen for OIC.

26 Feb 2013

Expanding Orthopedics initiates enrollment in XPED Expanding Pedicle Screw System study

Expanding Orthopedics Inc., a leading company in the area of expanding orthopedics devices, announced today that it has started to enroll patients in Germany for its multi-center post-market study to evaluate the performance and usability of the XPED Expanding Pedicle Screw System.

26 Feb 2013

Editorial explores caffeine-related toxicity and deaths

Caffeine-related toxicity, deaths, and near-deaths are an undeniable fact. In Sweden, for example, four people died as a result of confirmed caffeine-related causes in one year. Yet caffeine use continues to grow, including among young people, as it is increasingly added to a variety of drinks, foods, and weight-loss and other commonly used products.

26 Feb 2013

LINX device may help relieve chronic heartburn symptoms

Clinical trial results published in the New England Journal of Medicine this week offer additional evidence that a new device may help relieve chronic heartburn symptoms that standard treatment cannot. The Keck Medical Center of USC was one of 14 U.S. and European medical centers to test the device prior to its March 2012 approval by the U.S. Food and Drug Administration.

26 Feb 2013

Adynxx initiates AYX1 Phase 2 study to prevent post-surgical pain

Adynxx, a clinical-stage pharmaceutical company developing a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the first patient was dosed in a Phase 2 study of its lead investigational drug candidate for the prevention of post-surgical pain, AYX1.

26 Feb 2013

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

26 Feb 2013

Pain News and Research

Latest Pain News and Research

Adolescents with joint hypermobility more likely to develop musculoskeletal pain

Scientists identify two populations of human cells that migrate to the intestine

Anesthetics during breast cancer surgery may affect development of chronic pain

Primary care practices discriminating on socioeconomic status

Ampio Pharmaceuticals starts Optina clinical trial

Study shows people of high socioeconomic status more likely to get access to primary care

Offices of family physicians appear to give preference to people with chronic health conditions

New journal aims to address fatigue in medical illnesses and specific environmental conditions

Baxter files FEIBA NF BLA with FDA for prophylactic treatment of hemophilia A or B

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Learned helplessness role in inflammatory polyarthritis revealed

High-level results from AstraZeneca’s naloxegol Phase III trial on opioid-induced constipation

Expanding Orthopedics initiates enrollment in XPED Expanding Pedicle Screw System study

Editorial explores caffeine-related toxicity and deaths

LINX device may help relieve chronic heartburn symptoms

Adynxx initiates AYX1 Phase 2 study to prevent post-surgical pain

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

CT angiography uncovers cardiovascular disease risk

Opioids are main contributor to fatal overdoses

GLP-1 may increase risk of hospitalization for people with acute pancreatitis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in